
|Articles|February 26, 2010
Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration
Eye advance online publication 12 February 2010; doi: 10.1038/eye.2010.9
Advertisement
Eye advance online publication 12 February 2010; doi: 10.1038/eye.2010.9
Purpose: To assess the 1-year functional outcome and to evaluate the morphological changes after intravitreal injections of ranibizumab in eyes affected with retinal angiomatous proliferation (RAP) due to age-related macular degeneration (AMD).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FLORetina-ICOOR 2026: AI moves from the image to the trial, the clinic, and the operating room
2
Water-soluble CBD eye drops lower IOP and dampen corneal sensitivity in glaucoma mouse model
3
BL1332 misses primary end point in phase 2 post-PRK ocular pain study
4
Q&A: GLP-1 RAs and NAION, the case for a baseline exam
5











